Posted on

Bridging diagnostic gaps of drug-resistant pulmonary tuberculosis with clinical diagnosis in a low-and middle-income state, southwest Nigeria: A secondary data analysis

*[1]Irek, E. O., [2]Isinkaye, A. O., and [3]Orojo, J. A.

1Department of Medical Microbiology and Parasitology, Afe Babalola University/Afe Babalola University Multi-System Hospital, Ado-Ekiti, Nigeria

2Department of Community Medicine, Federal Teaching Hospital, Ido, Ekiti, Nigeria

3Tuberculosis Leprosy and Buruli Control Programme, Primary Health Care Development Agency, Ado-Ekiti, Nigeria

*Correspondence to: dj1irek@yahoo.com; +2348136833485; ORCID: 0000-0001-6363-6645

 

Abstract:

Background: Drug-resistant tuberculosis (DR-TB) poses a significant challenge to global TB control efforts, particularly in low- and middle-income countries (LMICs) where diagnostic resources are limited, thereby widening treatment gap. This has increased morbidity and mortality due to TB in Sub-Saharan Africa. We sought to evaluate the role of clinical diagnosis in identifying DR-TB in pulmonary TB cases missed by the sputum GeneXpert MTB/RIF assay in Ekiti State, Nigeria. Continue reading “Bridging diagnostic gaps of drug-resistant pulmonary tuberculosis with clinical diagnosis in a low-and middle-income state, southwest Nigeria: A secondary data analysis”